Riverbridge Partners’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
WA
ACM
CAM
FWIA
AC
YCM
Riverbridge Partners's MEDP Position: Q2 2026 in Review
Riverbridge Partners reduced its Medpace (MEDP) stake by 23% in Q2 2026, selling an estimated $24.7M and leaving 183,941 shares worth $97.4M. The position accounts for 2.72% of the portfolio, ranked #7.
Riverbridge Partners first reported a position in MEDP in Q1 2021 and has held it in 22 quarters since. The position peaked at $245M in Q1 2024. 72 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Riverbridge Partners held 183,941 shares of Medpace worth $97.4M as of Q2 2026.
- Riverbridge Partners sold 53,466 Medpace shares in Q2 2026, an estimated $24.7M.
- Medpace made up 2.72% of Riverbridge Partners's portfolio in Q2 2026, its #7 holding.
- Riverbridge Partners first reported a position in Medpace in Q1 2021 and has held it in 22 quarters since.
- Riverbridge Partners's Medpace position peaked at $245M in Q1 2024.
- 72 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.